Liran Belenzon, BenchSci co-founder and CEO

F-Prime backed start­up nabs an­oth­er $50M in bid to scale up AI R&D soft­ware

Al­most two years af­ter get­ting an in­fu­sion of cash from F-Prime and oth­er big in­vestors, Toron­to biotech Bench­Sci is back with more mon­ey in its cof­fers — and plans for ex­pan­sion.

The AI soft­ware start­up, which last raised $22 mil­lion in a 2020 Se­ries B, an­nounced that it now has raised $50 mil­lion in a Se­ries C this morn­ing, led by pre­vi­ous in­vestor In­ovia Cap­i­tal and new in­vestor TCV. In­ovia al­so led the start­up’s orig­i­nal Se­ries A raise. With the round now putting the com­pa­ny at $97 mil­lion raised, it gives the biotech more breath­ing room to ex­pand.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.